BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21850396)

  • 1. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
    Il'yasova D; Siamakpour-Reihani S; Akushevich I; Akushevich L; Spector N; Schildkraut J
    Breast Cancer Res Treat; 2011 Nov; 130(2):691-7. PubMed ID: 21850396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
    Hance KW; Anderson WF; Devesa SS; Young HA; Levine PH
    J Natl Cancer Inst; 2005 Jul; 97(13):966-75. PubMed ID: 15998949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
    Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
    Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.
    Levine PH; Portera CC; Hoffman HJ; Yang SX; Takikita M; Duong QN; Hewitt SM; Swain SM
    Clin Breast Cancer; 2012 Aug; 12(4):232-9. PubMed ID: 22694825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
    Anderson WF; Chu KC; Chang S
    J Clin Oncol; 2003 Jun; 21(12):2254-9. PubMed ID: 12805323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
    Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Cancer; 2011 May; 117(9):1819-26. PubMed ID: 21509759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program.
    Gudina AT; Copeland G; Soliman AS; Hirko KA
    Breast Cancer Res Treat; 2019 Feb; 173(3):693-699. PubMed ID: 30406365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].
    Benbrahim Z; Berrada A; Amaadour L; Zahra El M'rabet F; Elfatemi H; Elfakir S; Mellas N; Arifi S
    Gynecol Obstet Fertil Senol; 2017 Nov; 45(11):604-608. PubMed ID: 29100820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.
    Chang S; Parker SL; Pham T; Buzdar AU; Hursting SD
    Cancer; 1998 Jun; 82(12):2366-72. PubMed ID: 9635529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory breast cancer in the Netherlands; improved survival over the last decades.
    van Uden DJ; Bretveld R; Siesling S; de Wilt JH; Blanken-Peeters CF
    Breast Cancer Res Treat; 2017 Apr; 162(2):365-374. PubMed ID: 28138891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of inflammatory breast cancer in women, 1992-2009, United States.
    Goldner B; Behrendt CE; Schoellhammer HF; Lee B; Chen SL
    Ann Surg Oncol; 2014 Apr; 21(4):1267-70. PubMed ID: 24366421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.
    Schlichting JA; Soliman AS; Schairer C; Schottenfeld D; Merajver SD
    Breast Cancer Res Treat; 2012 Aug; 134(3):1257-68. PubMed ID: 22733221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
    Aurit SJ; Devesa SS; Soliman AS; Schairer C
    Breast Cancer Res Treat; 2019 Jun; 175(3):755-764. PubMed ID: 30915662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
    Hausauer AK; Keegan TH; Chang ET; Clarke CA
    Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database.
    Abraham HG; Xia Y; Mukherjee B; Merajver SD
    Breast Cancer Res Treat; 2021 Jan; 185(1):229-238. PubMed ID: 33033965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.
    Schlichting JA; Soliman AS; Schairer C; Banerjee M; Rozek LS; Schottenfeld D; Harford JB; Merajver SD
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):155-65. PubMed ID: 22028401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-18 (IL-18) is equally expressed in inflammatory breast cancer and noninflammatory locally advanced breast cancer: A possible association with chemotherapy response.
    Aguiar MAN; Wanderley CWS; Nobre LMS; Alencar MRM; Saldanha MDPS; Souza AM; Wong DVT; Barros PG; Almeida PRC; Lima-Júnior RCP; Ribeiro RA
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e138-e144. PubMed ID: 28766916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients.
    Arias-Pulido H; Cimino-Mathews AM; Chaher N; Qualls CR; Joste N; Colpaert C; Marotti JD; Chamberlin MD; Foisey MG; Prossnitz ER; Emens LA; Fiering S
    Breast Cancer Res Treat; 2021 Dec; 190(3):477-489. PubMed ID: 34542773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for inflammatory breast cancer and other invasive breast cancers.
    Schairer C; Li Y; Frawley P; Graubard BI; Wellman RD; Buist DS; Kerlikowske K; Onega TL; Anderson WF; Miglioretti DL
    J Natl Cancer Inst; 2013 Sep; 105(18):1373-84. PubMed ID: 24046390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.